SCHEMBL7028261

SCHEMBL7028261

C#C[C@@H]1CC[C@H]2[C@@H]3CCC4CCCC[C@@H]4[C@H]3CC[C@]12C

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 11/20 0.42
GABRB2 P47870 11/20 0.42
GABRP O00591 10/20 0.42
GABRD O14764 10/20 0.42
GABRB1 P18505 10/20 0.42
GABRG2 P18507 10/20 0.42
GABRB3 P28472 10/20 0.42
GABRA5 P31644 10/20 0.42
GABRA3 P34903 10/20 0.42
GABRA2 P47869 10/20 0.42
GABRA4 P48169 10/20 0.42
GABRE P78334 10/20 0.42
GABRA6 Q16445 10/20 0.42
GABRG1 Q8N1C3 10/20 0.42
GABRG3 Q99928 10/20 0.42
GABRQ Q9UN88 10/20 0.42
CYP17A1 P05093 1/20 0.41
SHBG P04278 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7025455 0.78 SHBG (0.44) CYP17A1SHBG
SCHEMBL12178067 0.77 SHBG (0.62) GABRA1GABRB2GABRPGABRDGABRB1
SCHEMBL4834980 0.77 GABRD (0.42) GABRA1GABRB2GABRPGABRDGABRB1
SCHEMBL4833944 0.77 GABRD (0.42) GABRA1GABRB2GABRPGABRDGABRB1
SCHEMBL16189884 0.77 SHBG (0.62) GABRA1GABRB2GABRPGABRDGABRB1
SCHEMBL23569462 0.77 GABRA1 (0.42) GABRA1GABRB2GABRPGABRDGABRB1
SCHEMBL15164711 0.77 SHBG (0.62) GABRA1GABRB2GABRPGABRDGABRB1
SCHEMBL12178022 0.77 SHBG (0.62) GABRA1GABRB2GABRPGABRDGABRB1
SCHEMBL22033067 0.75 GABRA1 (0.71) GABRA1GABRB2GABRPGABRDGABRB1
SCHEMBL7315413 0.75 GABRA1 (0.71) GABRA1GABRB2GABRPGABRDGABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994713-B1 USE OF A 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVE FOR THE TREATMENT OF ATHEROSCLEROSIS AKZO NOBEL NV (NL) 2003-11-05 EP claimed
EP-0169515-B1 17-HALOVINYL ESTRANE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN MEDICINES SCHERING AKTIENGESELLSCHAFT (DE) 1989-10-11 EP claimed